PA8626601A1 - DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS - Google Patents

DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS

Info

Publication number
PA8626601A1
PA8626601A1 PA8626601A PA8626601A PA8626601A1 PA 8626601 A1 PA8626601 A1 PA 8626601A1 PA 8626601 A PA8626601 A PA 8626601A PA 8626601 A PA8626601 A PA 8626601A PA 8626601 A1 PA8626601 A1 PA 8626601A1
Authority
PA
Panama
Prior art keywords
pharmaceutical compositions
dosage forms
methods
formulations
benzamida
Prior art date
Application number
PA8626601A
Other languages
Spanish (es)
Inventor
Krishnendu Ghosh
Arwinder S Nagi
Xiohong Pan
Melissa Lin
Leon Linberg
Ping Cia
Eric N C Browne
Michel Bernatchez
Mark Lankau
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PA8626601A1 publication Critical patent/PA8626601A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ESTA INVENCION SE REFIERE, POR EJEMPLO, A NUEVAS FORMULACIONES Y METODOS PARA LA LIBERACION DE 4-CIANO-N{(2R)-2-[4-(2,3-DIHIDRO-BENZO[1,4]DIOXIN-5IL]-PIPERAZIN-1-IL]-PROPIL]-N-PIRIDIN]-2-IL-BENZAMIDA, SALES FARMACEUTICAMENTE Y/O METABOLITOS; ASI COMO AL USO DE ESTAS FORMULACIONES Y METODOS PARA TRATAR ENFERMEDADES.THIS INVENTION REFERS, FOR EXAMPLE, TO NEW FORMULATIONS AND METHODS FOR THE RELEASE OF 4-CIANO-N {(2R) -2- [4- (2,3-DIHIDRO-BENZO [1,4] DIOXIN-5IL] - PIPERAZIN-1-IL] -PROPIL] -N-PIRIDIN] -2-IL-BENZAMIDA, PHARMACEUTICALLY SALTS AND / OR METABOLITES; AS WELL AS THE USE OF THESE FORMULATIONS AND METHODS TO TREAT DISEASES.

PA8626601A 2004-03-19 2005-03-18 DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS PA8626601A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55462204P 2004-03-19 2004-03-19

Publications (1)

Publication Number Publication Date
PA8626601A1 true PA8626601A1 (en) 2006-03-24

Family

ID=38063695

Family Applications (1)

Application Number Title Priority Date Filing Date
PA8626601A PA8626601A1 (en) 2004-03-19 2005-03-18 DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS

Country Status (5)

Country Link
CN (1) CN1956977A (en)
CR (1) CR8612A (en)
PA (1) PA8626601A1 (en)
SV (1) SV2006002054A (en)
ZA (1) ZA200607803B (en)

Also Published As

Publication number Publication date
SV2006002054A (en) 2006-02-15
CR8612A (en) 2007-10-02
ZA200607803B (en) 2009-09-30
CN1956977A (en) 2007-05-02

Similar Documents

Publication Publication Date Title
ECSP066866A (en) DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS REFERENCE TO RELATED APPLICATIONS
CL2007001918A1 (en) SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
UY29562A1 (en) AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
HN2004000490A (en) PROCEDURE FOR THE PREPARATION OF AN ORALLY ADMINISTRABLE SOLID PHARMACEUTICAL COMPOSITION
CL2009000349A1 (en) Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
ECSP066990A (en) FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO
UY27740A1 (en) NEW COMPOUNDS
CR8102A (en) DERIVATIVES OF PIRAZOLO-QUINAZOLINA, PROCEDURE FOR PREPARATION AND ITS USE AS QUINASE INHIBITORS
GT200500137A (en) USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS.
GT200500309A (en) DERIVATIVES OF SULFONILBENCILIMIDAZOL
SV2007002359A (en) PHARMACEUTICAL DOSAGE METHODS ADMINISTRABLE SOLIDS BY ROUTE WITH MODIFIED RELEASE REF. BHCO 41331 / SV
BRPI0508540B8 (en) compound, pharmaceutical composition, and use of a compound
BRPI0816881A2 (en) Compound, pharmaceutical composition, use of a compound, and methods for treating diseases or disorders and for preparing a compound.
UY30460A1 (en) THERAPEUTIC COMPOUNDS
SV2003001107A (en) IMIDAZOTRIAZINAS REF.LEA 35368
HN2004000319A (en) "{1,8} NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA"
CL2012002497A1 (en) Compounds derived from imidazopyrimidine, substituted, pde10a inhibitors; preparation procedure; pharmaceutical composition; and its use for the treatment or prevention of psychotic disorders, schizophrenia, parkinson's disease, multiple sclerosis, among others.
BRPI0618239A8 (en) use of flibanserin for the treatment of premenopausal sexual desire disorders
CL2008002162A1 (en) Compounds derived from 3-benzoisoxazole-piperidine; pharmaceutical composition comprising said compounds; and its use for the treatment and / or prevention of cognitive disorders, drug addiction, depression, anxiety, among others.
CL2007003832A1 (en) COMPOUNDS DERIVED FROM AZAESPIRO; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND ITS USE TO PREVENT AND TREAT ANXIETY, DEPRESSIVE DISORDERS, AMONG OTHER DISEASES.
CL2007001917A1 (en) COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS.
HN2006029142A (en) PROCESS
CL2011003144A1 (en) Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05).
PE20150773A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE
BRPI0516464A (en) pharmaceutical formulation, method for the preparation of a pharmaceutical, and use of a pharmaceutical formulation